Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | B4GALT1 | P15291 | 1/20 | 0.42 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.42 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.42 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.42 |
| ▸ | MDK | P21741 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HEXA | P06865 | 1/20 | 0.39 |
| ▸ | ANPEP | P15144 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20968783 | 0.90 | MAPK1 (0.55) | MAPK1B4GALT1LGALS3LGALS8LGALS4 | |
| SCHEMBL18735986 | 0.90 | MAPK1 (0.55) | MAPK1B4GALT1LGALS3LGALS8LGALS4 | |
| SCHEMBL15592393 | 0.90 | MAPK1 (0.55) | MAPK1B4GALT1LGALS3LGALS8LGALS4 | |
| SCHEMBL23602962 | 0.90 | MAPK1 (0.55) | MAPK1B4GALT1LGALS3LGALS8LGALS4 | |
| SCHEMBL30587044 | 0.89 | MAPK1 (0.46) | MAPK1B4GALT1LGALS3LGALS8LGALS4 | |
| SCHEMBL30634609 | 0.89 | MAPK1 (0.46) | MAPK1B4GALT1LGALS3LGALS8LGALS4 | |
| SCHEMBL21257124 | 0.89 | MAPK1 (0.55) | MAPK1B4GALT1LGALS3LGALS8LGALS4 | |
| SCHEMBL18736059 | 0.89 | MAPK1 (0.55) | MAPK1B4GALT1LGALS3LGALS8LGALS4 | |
| SCHEMBL22317580 | 0.89 | MAPK1 (0.55) | MAPK1B4GALT1LGALS3LGALS8LGALS4 | |
| SCHEMBL26933495 | 0.89 | MAPK1 (0.55) | MAPK1B4GALT1LGALS3LGALS8LGALS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230019098-A1 | BIVALENT COMPOUNDS, CONJUGATES AND USES THEREOF | RISEN (SHANGHAI) MEDICINAL TECH CO., LTD. (CN) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230019098-A1 | BIVALENT COMPOUNDS, CONJUGATES AND USES THEREOF | PLK1, BRDT, BCR | MAPK1 3879/4885B4GALT1 1007/4885LGALS3 2995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.